Jamie C. Barner, Ph.D., FAACP, FAPhA

Selected Recent Publications
*Denotes student(s)/trainee(s) at the time of the study.

CORE Research Area: Patient-Centered Outcomes Research

Bamgbade BA,* Barner JC, Brown CM, Ford KA, Burdine K, Lawson W. Impact of a psychoeducational intervention on willingness to seek help for depression among African American young adults. Transcultural Psychiatry. 2024;0:1-14. doi:10.1177/13634615241253167.

Mohan A,* Majd Z,* Johnson ML, Essien E, Barner JC, Serna O, Gallardo E, Fleming ML, Ordonez N, Holstad MM, Abughosh SM. A motivational interviewing intervention to improve adherence to ACEI/ARBs among nonadherent older adults with comorbid hypertension and diabetes. Drugs and Aging. 2023;40(4):377-390.

Lim H,* Barner JC. Impact of a workshop on student pharmacist confidence and comfort in counseling patients at risk for maternal mortality. Currents in Pharmacy Teaching and Learning. 2022;14(1):71-82.

Alshehri A,* Barner JC, Wong SL, Ibrahim K, Qureshi S. Perceptions among Muslims regarding fasting, medication use, and provider engagement during Ramadan. International Journal of Health Planning and Management. 2021;36:945-957.

Bamgbade BA,* Barner JC, Ford KH, Brown CM, Lawson WB, Burdine K. Willingness to seek help for depression in young African American adults: protocol for a mixed methods study. Journal of Medical Internet Research Protocol. 2020;9(2):e16267.

CORE Research Area: Healthcare Systems Research

Planas L, Unni E, Barner JC, Thomas T, Devraj R, Quinoñes-Boex A, Blakely L, Clark M, Irwin A, Nagel-Edwards K, Suda K, Zgarrick D, Young H, Nau D, Warholak T. Gender equity perceptions among social and administrative sciences pharmacy faculty: An AACP-APhA Task Force Report. Forthcoming American Journal of Pharmaceutical Education.

Barner JC, Quinoñes-Boex A, Warholak T. Gender inequity: Enough talk: Time for action. Journal of the American Pharmacists Association. 2022;21:S1544-3191(22)00286-2. doi: 10.1016/j.japh.2022.08.016.

Warholak T, Barner JC, Unni E, Thomas T, Devraj R, Quinoñes-Boex A, Blakely L, Clark M, Irwin A, Nagel-Edwards K, Suda K, Zgarrick D, Young H, Nau D, Planas L. Reliability and validity evidence for an academic gender equity questionnaire. American Journal of Pharmaceutical Education. 2022 Nov 4;ajpe9049. doi: 10.5688/ajpe9049.

Thomas T, Devraj R, Quinones-Boex A, Planas L, Unni E,  Barner JC, Blakely L, Clark M, Irwin A, Nagel-Edwards K, Suda K, Zgarrick D, Young H, Nau D, Warholak T. Gender equity perceptions among social and administrative science faculty:  a qualitative evaluation. Journal of the American Pharmacists Association. 2022;18:S1544-3191(22)00152-2.

CORE Research Area: Health Economics and Outcomes Research

Pennington E,* Barner JC, Brown CM, Lawson KA. Pregnancy-related risk factors and receipt of postpartum care among Texas Medicaid pregnant enrollees: Opportunities for pharmacist services. Journal of the American Pharmacists Association. 2024;64(1):260-267.

Kang HA, Barner JC, Rascati KL, Lawson KA, Mignacca RC. Impact of adherence to hydroxyurea on health outcomes among patients with sickle cell disease. American Journal of Hematology. 2023 Jan;98(1):90-101.

Zhang H,* Barner JC, Moczygemba LR, Rascati KL, Park C, Kodali D. Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010–2017. Breast Cancer Research and Treatment. 2022 doi 10.1007/s10549-022-06604-5.

Shukla N,* Barner JC, Lawson K, Rascati KL. Age-related healthcare services utilization for the management of sickle cell disease among Texas Medicaid patients. Journal of Pharmaceutical Health Services Research. 2021;12:523-530.

Shukla N,* Barner JC, Rascati KL, Lawson K. Age-related prescription medication utilization for the management of sickle cell disease among Texas Medicaid patients. Journal of Opioid Management. 2021;174(4):301-310.

Graduate Courses

• PGS 196S Seminar in Pharmacy (Topics: Healthcare Databases, Patient Reported Outcomes, Patient Experience)
• PGS 390K Experimental Design and Research Methods in Health Care (Topics: Research Designs, Threats to Internal and External Validity, Power Analysis)
• PGS 390J Data Analysis in Health Care (Topics: Coding, SAS)
• PGS 390U Advanced Research Methods (Topics: Medication Adherence, Network Meta-Analysis, Logistic Regression, Patient Experience)

PharmD Courses

• PHM 384L Pharmacy and the U.S. Health Care System (Topics: Utilization and Costs, Access to Care, Fraud and Abuse, Health Care Manpower, Hospitals, Long Term Care, Pharmaceutical Industry, Pharmacies)
• PHM 394F Principles of Pharmacoeconomics and Pharmacy Management (Topics: Human Resources Management, Health Information Technology, Risk Management)

Significant/Recent Activities

National and International Service Activities

American Association of Colleges of Pharmacy

• 2021-2022, Past Chair, Social and Administrative Sciences Section
• 2021-2022, Chair, Nominations Committee
• 2021-2022, Chair, New Investigator Award Committee
• 2020-present, Member, Gender Equity Task Force; Joint Effort with APhA
• 2020-2021, Chair, Social and Administrative Sciences Section
• 2019-2020, Chair, Annual Program Committee

American Pharmacists Association

• 2020-present Member, Gender Equity Task Force; Joint Effort with AACP
• 2020, Member, Assessing the Needs of Scientists in the Profession Working Group
• 2020, Member, Assessing the Needs of Scientists in the Profession Focus Group
• 2019, Judge, Podium Presentations at the 2019 Annual Meeting

University/College Service Activities
University

• 2019, Member, Consultative Committee for the Selection of a new Dean of the College of Pharmacy
• 2018-2023, Member, Texas Exes Scholarship Advisory Committee
• 2018-2020, Member, Faculty Council, College of Pharmacy Representative
• 2018-2020, Member, C-10 Recruitment and Retention Committee

College of Pharmacy

• 2024-present, Member, Opportunity and Engagement Committee
• 2022, 2023, Faculty Mentor, Leadership through Engagement for the Advancement of Diverse Educational Research (LEADER) program
• 2022-present, Member, Graduate Affairs and Curriculum Committee
• 2022-present, Concurrent Degrees, Pathways, and Programs Committee
• 2020-present, Advisory Board Member, Build Our Own Talent (BOOT) Program
• 2017-2023, Member, Diversity Equity, Accessibility, and Inclusion Committee
• 2015-present, Member, Translation Science PhD Committee on Graduate Studies
• 2009-2021, PharmD/PhD Oversight Committee
• 2000-present, Co-Advisor, Student National Pharmaceutical Association

Centers for Disease Control Grants

• Innovative State and Local Public Health Strategies to Prevent and Manage Diabetes and Heart Disease and Stroke CDC-RFA-DP18-1815
• Innovative State and Local Public Health Strategies to Prevent and Manage Diabetes and Heart Disease and Stroke CDC-RFA-DP18-1817
  • Clague M,* Travillion P,* Barner JC, Wallace Gay T, Rush S, Davis P. “Influence of medication therapy management (MTM) workshop on student pharmacists’ confidence in engaging in interprofessional collaboration: Results from three institutions,” at the American Society of Health-Systems Pharmacists Midyear Clinical Meeting, Las Vegas, NV, December 4-8, 2022.
  • Barner JC, Moczygemba LR, Davis P, Cuevas J, George E, Rush S, Travillion P,* Clague M,* “Impact of a medication therapy management workshop on student pharmacists’ confidence in engaging providers in collaboration: results from four institutions” at the American Pharmacists Association Annual Meeting, San Antonio, TX, March 18-21, 2022. (Podium)
  • Moczygemba LR, Barner JC, Tucker A, McNabb, Miller A,* “Implementation and perceptions of a program to support diabetes self-management education and support accreditation of Texas pharmacies” at the American Pharmacists Association Annual Meeting, San Antonio, TX, March 18-21, 2022. (Talking Poster)
  • Barner JC, Moczygemba LR, Rush S, Travillion P,* Clague M,* “Medication therapy management and diabetes self-management education and support in Texas colleges/schools of pharmacy” at the American Association of Colleges of Pharmacy Annual Meeting (virtual), July 19-22, 2021.
  • Barner JC, Moczygemba LR, Pope N, Clague M,* Travillion P,* “Medication therapy management and diabetes self-management education and support in Texas community-based pharmacy residency programs” at the American Pharmacists Association Annual Meeting (virtual),  March 12-15, 2021. (Podium)
  • Hudzik A,* Moczygemba LR, Barner JC, Wallace-Gay T, Semwal M, “Texas community pharmacists and MTM services” at the American Pharmacists Association Annual Meeting (virtual),  March 12-15, 2021.
  • Barner JC, Hughes PJ, Moczygemba LR, Pinto S, Sisson E, “Strategies for engaging community partners, healthcare professionals, and students: Research experiences from four institutions” at the American Association of Colleges of Pharmacy Annual Meeting (virtual) July 18-20, 2020. (Podium)

Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Grant

• Predoctoral Fellowship in Health Outcomes Research (Student PI: Hanxi “Molly” Zhang; Co-Faculty PIs: Drs. Barner and Moczygemba)
  • Zhang H,* Barner JC, Moczygemba LR, Rascati K, Park C, Kodali D, “2010–2017 trends of neoadjuvant chemotherapy use among older women with breast cancer: A SEER-Medicare analysis” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Washington, DC, May 15-18, 2022.
  • Zhang H,* Barner JC, Moczygemba LR, Rascati KL, Park C, Kodali D. Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010–2017. Breast Cancer Research and Treatment. 2022 doi 10.1007/s10549-022-06604-5.

Focus on Sickle Cell Disease

• Patient Outcomes
  • Ibiloye E,* Odonkor G,* Barner JC, Brown CM, Kang HK, Bamgbade BA. “Factors influencing willingness to utilize the emergency department among individuals living with sickle cell disease” at the International Society for Pharmacoeconomics and Outcomes Research 2024. Atlanta, GA. May 5-8, 2024
  • Kang HA, Wang B, Barner JC, Ataga KI, and Mignacca RC, “Unintended consequences of the CDC’s 2016 opioid guideline on individuals with sickle cell disease,” at the American Association of Colleges of Pharmacy 2023 Annual Meeting, Aurora, CO, July 22-25, 2023.
  • Ibiloye E,* Odonkor G,* Barner JC, Brown CM, Kang HK, Bamgbade BA,*  “Beliefs regarding patient experience in the emergency department among individuals living with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Boston, MA, May 7-10, 2023.
• Healthcare Utilization and Costs among Texas Medicaid Patients with Sickle Cell Disease
  • Odonkor G,* Barner JC, Kang HA, Fasipe T. “Examination of age-related medical complications among pediatric, adolescent, and young adult patients with sickle cell disease in Texas Medicaid” at the International Society for Pharmacoeconomics and Outcomes Research 2024. Atlanta, GA. May 5-8, 2024. (Best Student Podium Award and Top 5% Finalist)
  • Kang HA, Wang B, Barner JC, Ataga KI, and Mignacca RC, “Unintended Consequences of the CDC’s 2016 Opioid Guideline on Individuals with Sickle Cell Disease,” at the American Association of Colleges of Pharmacy 2023 Annual Meeting, Aurora, CO, July 22-25, 2023.
  • Shukla N,* Barner JC, Rascati KL, Lawson K, “Prescription medication utilization for the management of sickle cell disease by age group” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting (virtual), May 16-20, 2020.
  • Shukla N,* Barner JC, Rascati KL, Lawson K, “Age-related healthcare service utilization in sickle cell disease management” at Academy of Managed Care Pharmacy Annual Meeting (virtual), April 21-24, 2020.
  • Kang HA,* Barner JC, Rascati KL, Lawson KA, Mignacca RC, “Association between hydroxyurea medication adherence and all-cause and disease-related healthcare expenditures among Texas Medicaid enrollees with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, New Orleans, LA, May 18-22, 2019.
  • Barner JC, Kang HA,* Richards K, Bhor M, Paulose J, Kutlar A, “Association between vaso-occlusive crises and opioid use among Texas Medicaid recipients with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, New Orleans, LA, May 18-22, 2019.
  • Barner JC, Kang HA,* Richards K, Bhor M, Paulose J, Kutlar A, “Association between hydroxyurea adherence and persistence and vaso-occlusive crises among Texas Medicaid recipients with sickle cell disease” at Academy of Managed Care Pharmacy Annual Meeting, San Diego, CA, March 26-28, 2019.
  • Kang HA,* Barner JC, “Hydroxyurea medication adherence and opioid use among Texas Medicaid enrollees with sickle cell disease” at the American Pharmacists Association Annual Meeting, Seattle, WA, March 22-25, 2019.
  • Kang HA,* Barner JC, Rascati KL, Lawson KA, Mignacca RC “Association between hydroxyurea medication adherence and vaso-occlusive crisis events among Texas Medicaid enrollees with sickle cell disease” at the International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Baltimore, MD, May 19-23, 2018.
  • Shukla N,* Barner JC, “Temporal use of medications for the management/treatment of sickle cell disease” at the Academy of Managed Care Pharmacy Annual Meeting, Boston, MA, April 23-26, 2018.